Invesco
ODTX icon

Invesco’s Odyssey Therapeutics ODTX Stock Holding History

Invesco’s Portfolio ODTX Stock Details ODTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$305K Buy
+13,706
New +$291K ﹤0.01% 3444

Other funds holding ODTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Lightspeed Management Company
Lightspeed Management Company Menlo Park, California $2.03B AUM 10.68% 1-Year Est. Return
Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Sands Capital Ventures
Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Invesco's ODTX Position: Q3 2026 in Review

Invesco opened a new position in Odyssey Therapeutics (ODTX) in Q3 2026: 13,706 shares worth $305K. The stake represents ﹤0.01% of the portfolio and ranks #3444 among its holdings.

41 funds tracked by Wall St. Rank hold ODTX as of Q3 2026.

  • Invesco held 13,706 shares of Odyssey Therapeutics worth $305K as of Q3 2026.
  • Odyssey Therapeutics was a new Invesco position in Q3 2026.
  • Odyssey Therapeutics made up ﹤0.01% of Invesco's portfolio in Q3 2026, its #3444 holding.
  • 41 funds tracked by Wall St. Rank held Odyssey Therapeutics as of Q3 2026.

Based on Invesco's 13F filing for Q3 2026, filed 12 Nov 2026.